Analysis of the coagulant activity of such EV under in vitro or in vivo conditions shows discrepancies; while TF-EVs show coagulant activity in cell culture setups, such coagulant activity appears limited in the plasma of cancer patients with VTE [6, 7, 10]. Here, TF is linked to cancer.